IQVIA (IQV)
(Delayed Data from NYSE)
$182.45 USD
-3.41 (-1.83%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $182.44 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, IQVIA Holdings Inc. has a PEG ratio of 1.91 compared to the Medical - Instruments industry's PEG ratio of 2.25.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IQV 182.45 -3.41(-1.83%)
Will IQV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IQV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IQV
Verisk Earnings & Revenues Surpass Estimates in Q2, Increase Y/Y
WM Earnings & Revenues Beat Estimates in Q2, Increase Y/Y
IQV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Fiserv Q2 Earnings Beat Estimates on Strong Margins, Revenues Miss
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
IQVIA (IQV) Reliance on International Sales: What Investors Need to Know
Other News for IQV
Notable healthcare headlines for the week: Pfizer, UnitedHealth, Sarepta and Thermo Fisher in focus
What Moved Markets This Week
IQV Stock Target Price Raised to $225 by Mizuho Analyst | IQV Stock News
Iqvia price target raised by $35 at Mizuho, here's why
IQVIA Holdings (IQV): Mizuho Raises Price Target to $225 | IQV Stock News